United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Bora Pharmaceuticals set to shake up rare disease treatment with Pyros Pharmaceuticals acquisition Bora Pharmaceuticals Co., Ltd. is intensifying its presence in the rare disease treatment market by acquiring U.S.-based Pyros… byPallavi MadhirajuOctober 27, 2024